Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort

Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials

(2012) PM Villa et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

(2012) Sarosh Rana et al.   CIRCULATION

Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis

(2012) Stéphanie Roberge et al.   FETAL DIAGNOSIS AND THERAPY

Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia

(2012) Tinnakorn Chaiworapongsa et al.   Journal of Maternal-Fetal & Neonatal Medicine

A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy

(2011) MARIA PALM et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients

(2011) Stefan Verlohren et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Preeclampsia, a Disease of the Maternal Endothelium

(2011) Camille E. Powe et al.   CIRCULATION

Serum placental growth factor and fms-like tyrosine kinase 1 during first trimester in Chinese women with pre-eclampsia – a case–control study

(2011) Lai Wa Law et al.   Journal of Maternal-Fetal & Neonatal Medicine

Soluble Flt-1 and PlGF: New Markers of Early Pregnancy Loss?

(2011) Shanthi Muttukrishna et al.   PLoS One

Prospective Study of Placental Angiogenic Factors and Maternal Vascular Function Before and After Preeclampsia and Gestational Hypertension

(2010) Muna Noori et al.   CIRCULATION

Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia

(2009) Mahmoud Shokry et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

First-Trimester Prediction of Hypertensive Disorders in Pregnancy

(2009) Leona C.Y. Poon et al.   HYPERTENSION

PAPP-A and free ß-hCG stability in first trimester serum using PerkinElmer AutoDELFIA®and DELFIA®Xpress systems

(2009) Nicholas J. Cowans et al.   PRENATAL DIAGNOSIS

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate

(2008) Roberto Romero et al.   Journal of Maternal-Fetal & Neonatal Medicine

Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia

(2008) R. Akolekar et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY